ADRA2A Antibody

Code CSB-PA001388LA01HU
Size US$166
Order now
  • Immunofluorescent analysis of MCF-7 cells using CSB-PA001388LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) ADRA2A Polyclonal antibody
Uniprot No.
Target Names
Alternative Names
ADRA2A; ADRA2R; ADRAR; Alpha-2A adrenergic receptor; Alpha-2 adrenergic receptor subtype C10; Alpha-2A adrenoreceptor; Alpha-2A adrenoceptor; Alpha-2AAR
Raised in
Species Reactivity
Recombinant Human Alpha-2A adrenergic receptor protein (218-374AA)
Immunogen Species
Homo sapiens (Human)

The ADRA2A Antibody (Product code: CSB-PA001388LA01HU) is Non-conjugated. For ADRA2A Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA001388LB01HU ADRA2A Antibody, HRP conjugated ELISA
FITC CSB-PA001388LC01HU ADRA2A Antibody, FITC conjugated
Biotin CSB-PA001388LD01HU ADRA2A Antibody, Biotin conjugated ELISA
Purification Method
>95%, Protein G purified
It differs from different batches. Please contact us to confirm it.
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Tested Applications
Recommended Dilution
Application Recommended Dilution
IF 1:50-1:200
Troubleshooting and FAQs
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol.
Gene References into Functions
  1. Rs1800544 polymorphism is associated with bone turnover markers level in Chinese elderly individuals with osteoporotic fractures, indicating the involvement of genetic variation of a2A-AR gene in bone metabolism. PMID: 30033441
  2. ADRA2A genetic variation contributes independently to the risk of GDM in Caucasian women. PMID: 28976299
  3. Results describe association of ADRA2A rs553668 with type 2 diabetes in a Mexican population. PMID: 29800730
  4. Significant group*genotype interactions were found for 3 ADRA2A variants revealing steeper delay discounting (DD) in cocaine users (but not controls) carrying the G-allele of rs1800544, the T-allele of rs521674 and the C-allele of rs602618. High ADRA2A mRNA expression levels were significantly associated with a reduced tendency to choose smaller more immediate rewards in cocaine users. PMID: 26549422
  5. The summary of this study, none of the examined variants reached the threshold for statistical significance after correction for multiple testing. The SNP rs1800544 in ADRA2A, revealed nominally significant association, but the direction of effect was the opposite to that reported in previous studies conducted in children and adolescents. PMID: 27091191
  6. The results of this study suggested that ADRA2A rs3750625 contributes to poststress musculoskeletal pain severity by modulating miR-34a regulation PMID: 27805929
  7. This study reveled that ADA2A are up regulate in peripheral blood mononuclear cells in patient with multiple sclerosis. PMID: 27609280
  8. Results show that ADRA2A genetic variants are associated with blood glucose and stress-induced hyperglycemia after acute myocardial infarction in Caucasians. PMID: 27131769
  9. These findings suggest that Gi1 interacts only with active GPCRs and that the well known high speed of GPCR signal transduction does not require preassembly between G proteins and GPCRs. PMID: 28438833
  10. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer. PMID: 26563278
  11. The ADRA2A C-1291G and COMT Val158Met genotypes and sex interact in predicting detection and perception of emotional valence in facial expressions PMID: 26234518
  12. ADRA2a is associated with heart rate recovery after exercise. PMID: 26058836
  13. Study is in line with previous reports of an association between ADRA2A gene variants and general reaction time variability during response selection tasks PMID: 25978426
  14. Genetic association of ADRA2A single nucleotide polymorphism with metabolic syndrome and high level insulin among the Tatars PMID: 26410938
  15. The rs10885122G>T polymorphism of the ADRA2A gene was not associated with type 2 diabetes mellitus in Euro-Brazilians, and carriers of the T allele had lower body weight in the presence of type 2 diabetes mellitus. PMID: 25926111
  16. Common polymorphisms in the ADRA2A gene are not associated with orthostatic hypotension risk in Chinese. PMID: 26427149
  17. The alpha2a AR expression in breast cancer was associated with Her-2 status (P = 0.048) and a marginal significance was observed between alpha2a AR expression and estrogen receptor (P = 0.061). PMID: 24559182
  18. Study found evidence that DNA variation in the ADRA2A gene may be causally related to ADHD-like behaviors, in part through its influence on intra-individual variability PMID: 24166412
  19. The accuracy of prediction for breast cancer relapse based solely on the expression of ADRA2A gene is high. PMID: 25110082
  20. Results show that ADRA2A genotype was associated with clozapine-induced sialorrhea PMID: 25163438
  21. Common polymorphisms in ADRA2A do not affect plasma membrane trafficking. PMID: 24643471
  22. No significant association was observed between alpha2-adrenergic receptor gene C-1291G polymorphism and irritable bowel syndrome in Turkish population. PMID: 24623286
  23. The study data indicated that carriage of the ADRA2A rs1800544 GG genotype was associated with body mass index reduction in schizophrenia patients following switching of antipsychotics to aripiprazole and ziprasidone. PMID: 24424705
  24. The ADRA2A gene is associated with withdrawn behavior and reinforces the role of catecholaminergic genes in the heritability of withdrawn behavior. PMID: 23808549
  25. We identified the c.1138 C>A (p.Arg380Arg) silent substitution. We conclude that ADRA2A non-synonymous sequence variants do not cause ADHD in our sample population. PMID: 24178896
  26. Cultured Achilles tendon tenocyte proliferation is induced by ADRA2A stimulation and inhibited by an ADRA2A blocker. PMID: 22292987
  27. 6.3-kb alpha2A-AR variant is associated with increased platelet reactivity to epinephrine and has an additive effect along with CYP2C19*2 loss-of-function allele on P2Y12-mediated platelet responses in patients with stable angina on dual antiplatelet therapy PMID: 24723553
  28. The present investigation reports results from a meta-analysis of family-based studies that did not find a significant association between the MspI polymorphism of the ADRA2A gene and attention-deficit hyperactivity disorder. PMID: 23751900
  29. The results of this study postulated that ADRA2A would have effects on attentional performance and white-matter abnormalities, particularly in frontal regions. PMID: 24026714
  30. Analysis of schizophrenic's MTHFR*ADRA2A (C677T*C-1291G) interaction revealed significant association between ADRA2A CC+CG genotype in the MTHFR TC+TT carriers (p=0.008). PMID: 24522021
  31. ADRA2A genetic polymorphisms are mainly associated with obesity and possibly with T2D in a Swedish population. PMID: 23526671
  32. The results of this study suggest that DNA variants of both SLC6A2 and ADRA2A in the adrenergic neurotransmitter system might alter the response to atomoxetine. PMID: 23266789
  33. The AA genotype of rs553668 in ADRA2A might be a genetic risk factor that increases type 2 diabetes mellitus susceptibility. [Meta-analysis] PMID: 23462695
  34. Allelic association between schizophrenia and the ADRA2A rs1800544 polymorphism was found, but it did not survive correction for multiple testing. PMID: 22940547
  35. the ADRA2A polymorphism, rs553668, is associated with lean type 2 diabetes patients in a Chinese Han population. PMID: 23153004
  36. Impulsive personality is an important predictor of risky driving. In alpha(2A)-adrenoceptor gene (ADRA2A) G allele carriers, general traffic risk and speeding decreased in response to the intervention, unlike in subjects with the CC genotype. PMID: 22694918
  37. The ADRA2A and ADRA2C polymorphisms did not contribute to an increased risk of ischemic stroke or any pathophysiological subtype PMID: 22560155
  38. The mortality rate of chronic systolic heart failure patients carrying no alpha(2c)-adrenoceptor Del322-325 alleles was significantly higher (almost 2.5-fold) than that of HF patients carrying >/=1 allele. PMID: 23207081
  39. genetic polymorphisms in the adrenergic system may not play a major role in antipsychotic-induced weight gain; however, adrenergic 2A receptor gene showed a significant interaction with the monoamine oxidase A in weight gainers PMID: 21823169
  40. The small GTPase Rab26 regulates the Golgi to cell surface traffic of alpha(2)-adrenergic receptors, likely through a physical interaction. PMID: 23105096
  41. the rs553668 polymorphism is associated with glucose worsening in subjects without diabetes at baseline PMID: 22061269
  42. In young African Americans, the -1291C/G promoter polymorphism in the alpha(2A) -AR gene was associated with vascular reactivity to stress; vasoconstriction increased as a linear function of the number of copies of the variant G allele. PMID: 22091949
  43. ADRA2A is involved in pre- and post-synaptic inhibition of norepinephrine signalling. PMID: 21070505
  44. Inhibition of ADRA2A receptor selectively prevents memory decline without altering beta-amyloid plaque or astrocytosis. PMID: 20850464
  45. Results describe the association between the effect of alpha(2A)-Adrenergic Receptor (ADRA2A) C-1291G gene polymorphism in the promoter region of the candidate gene and clinical effects (sedative and haemodynamics effects) of dexmedetomidine. PMID: 21104443
  46. Multiple ADRA2A SNPs are associated with metabolic traits, blood pressure and type 2 diabetes risk. PMID: 21455730
  47. neonatal ADRB2 p.Arg16 homozygosity, but not nitric oxide synthase genotype, confers a protective effect against developing ephedrine-induced fetal acidemia PMID: 21613201
  48. The genetic variants in ADRA2A are associated with different blood pressure responses to the selective alpha 2-selective agonist dexmedetomidine. PMID: 21325151
  49. Antecedent hypoglycaemia did not affect beta(2)-adrenergic receptor sensitivity in healthy GlyGly participants. PMID: 21298412
  50. This study do not support a significant role for the ADRA2A gene in ADHD pharmacogenetics, at least among adult patients. PMID: 21103886

Show More

Hide All

Subcellular Location
Cell membrane; Multi-pass membrane protein.
Protein Families
G-protein coupled receptor 1 family, Adrenergic receptor subfamily, ADRA2A sub-subfamily
Database Links

HGNC: 281

OMIM: 104210

KEGG: hsa:150

STRING: 9606.ENSP00000280155

UniGene: Hs.249159

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details


II. Contact details


III. Ship To


IV. Bill To